(d) Where there is some sharing of both MHC class I and class II molecules, the fusions express allogeneic MHC class I and class II molecules derived from semi-allogeneic DCs for direct stimulation of the patient's CD4+ T cells as well as all the patient's HLA class I and class II molecules for autologous MHC-restricted tumor peptide presentation. Here, HLA-C is linked to neoplasm.